Published in Eur J Immunol on July 01, 2005
Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell (2015) 5.10
LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems. J Clin Invest (2007) 2.57
Functionally distinct LAG-3 and PD-1 subsets on activated and chronically stimulated CD8 T cells. J Immunol (2009) 1.60
LAG-3 in Cancer Immunotherapy. Curr Top Microbiol Immunol (2011) 1.58
LAG-3 regulates plasmacytoid dendritic cell homeostasis. J Immunol (2009) 1.33
Beyond CTLA-4 and PD-1, the Generation Z of Negative Checkpoint Regulators. Front Immunol (2015) 1.01
Clinical impact of checkpoint inhibitors as novel cancer therapies. Drugs (2014) 0.99
Role of lymphocyte activation gene-3 (Lag-3) in conventional and regulatory T cell function in allogeneic transplantation. PLoS One (2014) 0.96
Malaria drives T cells to exhaustion. Front Microbiol (2014) 0.90
The emergence of ADAM10 as a regulator of lymphocyte development and autoimmunity. Mol Immunol (2011) 0.88
Lymphocyte Activation Gene-3 (LAG-3) negatively regulates environmentally-induced autoimmunity. PLoS One (2014) 0.86
LAG3 expression in active Mycobacterium tuberculosis infections. Am J Pathol (2014) 0.85
Upregulation of Immune Checkpoint Molecules, PD-1 and LAG-3, on CD4+ and CD8+ T Cells after Gastric Cancer Surgery. Yonago Acta Med (2015) 0.84
Common single nucleotide polymorphisms in immunoregulatory genes and multiple myeloma risk among women in Connecticut. Am J Hematol (2010) 0.81
Programmed death-1 checkpoint blockade in acute myeloid leukemia. Expert Opin Biol Ther (2015) 0.79
Lymphocyte activation gene-3 expression defines a discrete subset of HIV-specific CD8+ T cells that is associated with lower viral load. AIDS Res Hum Retroviruses (2013) 0.79
T cell exhaustion: from pathophysiological basics to tumor immunotherapy. Cell Commun Signal (2017) 0.78
Gene expression profiling of the response to interferon beta in Epstein-Barr-transformed and primary B cells of patients with multiple sclerosis. PLoS One (2014) 0.78
Update on hepatitis C virus-specific immunity. Curr Opin HIV AIDS (2011) 0.78
Profiling the dynamic expression of checkpoint molecules on cytokine-induced killer cells from non-small-cell lung cancer patients. Oncotarget (2016) 0.78
Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells. J Neuroinflammation (2015) 0.77
Poxvirus-Based Active Immunotherapy with PD-1 and LAG-3 Dual Immune Checkpoint Inhibition Overcomes Compensatory Immune Regulation, Yielding Complete Tumor Regression in Mice. PLoS One (2016) 0.77
High expression of lymphocyte-activation gene 3 (LAG3) in chronic lymphocytic leukemia cells is associated with unmutated immunoglobulin variable heavy chain region (IGHV) gene and reduced treatment-free survival. J Mol Diagn (2010) 0.77
LAG3 (CD223) as a cancer immunotherapy target. Immunol Rev (2017) 0.77
Lymphocyte-activation gene-3, an important immune checkpoint in cancer. Cancer Sci (2016) 0.76
Lymphocyte activation gene 3 and coronary artery disease. JCI Insight (2016) 0.75
Immune checkpoint inhibitors: the new frontier in non-small-cell lung cancer treatment. Onco Targets Ther (2016) 0.75
IL-21R on T cells is critical for sustained functionality and control of chronic viral infection. Science (2009) 3.90
IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo. Eur J Immunol (2008) 2.58
Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk. J Clin Invest (2012) 1.58
Bacterial-induced protection against allergic inflammation through a multicomponent immunoregulatory mechanism. Thorax (2011) 1.49
SCART scavenger receptors identify a novel subset of adult gammadelta T cells. J Immunol (2008) 1.45
Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis. Eur J Immunol (2011) 1.37
Structures of two streptococcal superantigens bound to TCR beta chains reveal diversity in the architecture of T cell signaling complexes. Structure (2002) 1.31
The kinase activity of Rip2 determines its stability and consequently Nod1- and Nod2-mediated immune responses. J Biol Chem (2009) 1.02
Cutting edge: Clec9A+ dendritic cells mediate the development of experimental cerebral malaria. J Immunol (2012) 1.01
Quantifying the energetics of cooperativity in a ternary protein complex. Biochemistry (2002) 0.92
Structural, energetic, and functional analysis of a protein-protein interface at distinct stages of affinity maturation. Structure (2003) 0.91
An epigenetic profile of early T-cell development from multipotent progenitors to committed T-cell descendants. Eur J Immunol (2014) 0.88
Induced pluripotent stem cells expressing elevated levels of sox-2, oct-4, and klf-4 are severely reduced in their differentiation from mesodermal to hematopoietic progenitor cells. Stem Cells Dev (2011) 0.87
Transient ablation of alveolar macrophages leads to massive pathology of influenza infection without affecting cellular adaptive immunity. Eur J Immunol (2014) 0.86
IL-21 induces death of marginal zone B cells during chronic inflammation. Blood (2010) 0.86
The CD3 gamma leucine-based receptor-sorting motif is required for efficient ligand-mediated TCR down-regulation. J Immunol (2002) 0.83
Manipulation of immune system via immortal bone marrow stem cells. Int Immunol (2008) 0.80
Evidence for the divergence of innate and adaptive T-cell precursors before commitment to the αβ and γδ lineages. Blood (2011) 0.79